Search results
Results from the WOW.Com Content Network
Dana–Farber Cancer Institute (DFCI) is a comprehensive cancer treatment and research center in Boston, Massachusetts.Dana-Farber is the founding member of the Dana-Farber/Harvard Cancer Center, Harvard's Comprehensive Cancer Center designated by the National Cancer Institute, and one of the 15 clinical affiliates and research institutes of Harvard Medical School.
John Quackenbush is an American computational biologist and genome scientist.He is a professor of biostatistics and computational biology and a professor of cancer biology at the Dana–Farber Cancer Institute (DFCI), [1] [2] [3] as well as the director of its Center for Cancer Computational Biology (CCCB). [4]
Matthew Langer Meyerson (born June 4, 1963) is an American pathologist and the Charles A. Dana Chair in Human Cancer Genetics at the Dana-Farber Cancer Institute. [1] He is also director of the Center for Cancer Genomics at the Dana-Farber Cancer Institute, [2] and the Director of Cancer Genomics at the Broad Institute of MIT and Harvard.
2 Career and research interests. 3 Recognition. ... Gordon J. Freeman is an American immunologist and oncologist at the Dana-Farber Cancer Institute and Harvard ...
Griffin completed his residency at Johns Hopkins Hospital, a hematology fellowship at Massachusetts General Hospital, and a medical oncology fellowship at Dana–Farber Cancer Institute. [3] He is on the scientific advisory boards of Phio Pharmaceuticals, the Georgetown Lombardi Comprehensive Cancer Center, and the Johns Hopkins Cancer Center. [4]
Her laboratory consider the evolutionary dynamics of cancer, including its initiation, progression, response to therapy, and emergence of resistance. [6] She moved to the Dana–Farber Cancer Institute in 2010, where she was promoted to Professor in 2015.
Dana–Farber Cancer Institute Toni K. Choueiri is a Lebanese American medical oncologist and researcher. He is the Jerome and Nancy Kohlberg Professor of Medicine at Harvard Medical School and director of the Lank Center for Genitourinary Oncology at the Dana–Farber Cancer Institute .
Catherine J. Wu is an American physician-scientist who studies oncology. She is a Professor of Medicine and Chief of Division of Stem Cell Transplantation and Cellular Therapies at the Dana–Farber Cancer Institute.